{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:17:37Z","timestamp":1772155057906,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA225830"],"award-info":[{"award-number":["CA225830"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["3R01CA225830-01S1"],"award-info":[{"award-number":["3R01CA225830-01S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Recent studies have shown that bone morphogenetic protein receptor 2 (BMPR2) regulates cell survival signaling events in cancer cells independent of the BMP type 1 receptor (BMPR1) or the Smad-1\/5 transcription factor. Mutations in BMPR2 trafficking proteins leads to overactive BMP signaling, which leads to neurological diseases caused by BMPR2 stabilization of the microtubules. It is not known whether BMPR2 regulates the microtubules in cancer cells and what effect this has on cell survival. It is also not known whether alterations in BMPR2 trafficking effects activity and response to BMPR2 inhibitors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We utilized BMPR2 siRNA and the BMP receptor inhibitors JL5 and Ym155, which decrease BMPR2 signaling and cause its mislocalization to the cytoplasm. Using the JL5 resistant MDA-MD-468 cell line and sensitive lung cancer cell lines, we examined the effects of BMPR2 inhibition on BMPR2 mislocalization to the cytoplasm, microtubule destabilization, lysosome activation and cell survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We show that the inhibition of BMPR2 destabilizes the microtubules. Destabilization of the microtubules leads to the activation of the lysosomes. Activated lysosomes further decreases BMPR2 signaling by causing it to mislocalizated to the cytoplasm and\/or lysosome for degradation. Inhibition of the lysosomes with chloroquine attenuates BMPR2 trafficking to the lysosome and cell death induced by BMPR2 inhibitors. Furthermore, in MDA-MD-468 cells that are resistant to JL5 induced cell death, BMPR2 was predominately located in the cytoplasm. BMPR2 failed to localize to the cytoplasm and\/or lysosome following treatment with JL5 and did not destabilize the microtubules or activate the lysosomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These studies reveal that the inhibition of BMPR2 destabilizes the microtubules promoting cell death of cancer cells that involves the activation of the lysosomes. Resistance to small molecules targeting BMPR2 may occur if the BMPR2 is localized predominantly to the cytoplasm and\/or fails to localize to the lysosome for degradation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12964-021-00743-w","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T17:02:47Z","timestamp":1632589367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Arindam","family":"Mondal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"NeMoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehul","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoya","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Langenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gilleran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Rongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Langenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"743_CR1","doi-asserted-by":"publisher","first-page":"e41460","DOI":"10.1371\/journal.pone.0041460","volume":"7","author":"A Sountoulidis","year":"2012","unstructured":"Sountoulidis A, Stavropoulos A, Giaglis S, Apostolou E, Monteiro R, Chuva de Sousa Lopes SM, Chen H, Stripp BR, Mummery C, Andreakos E, Sideras P. Activation of the canonical bone morphogenetic protein (bmp) pathway during lung morphogenesis and adult lung tissue repair. PLoS ONE. 2012;7:e41460.","journal-title":"PLoS ONE"},{"key":"743_CR2","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1242\/dev.126.18.4005","volume":"126","author":"M Weaver","year":"1999","unstructured":"Weaver M, Yingling JM, Dunn NR, Bellusci S, Hogan BL. Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development. Development. 1999;126:4005\u201315.","journal-title":"Development"},{"key":"743_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/carcin\/bgg100","volume":"24","author":"EM Langenfeld","year":"2003","unstructured":"Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis. 2003;24:1445\u201354.","journal-title":"Carcinogenesis"},{"key":"743_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.athoracsur.2005.03.094","volume":"80","author":"EM Langenfeld","year":"2005","unstructured":"Langenfeld EM, Bojnowski J, Perone J, Langenfeld J. Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg. 2005;80:1028\u201332.","journal-title":"Ann Thorac Surg"},{"key":"743_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1541-7786.141.2.3","volume":"2","author":"EM Langenfeld","year":"2004","unstructured":"Langenfeld EM, Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res. 2004;2:141\u20139.","journal-title":"Mol Cancer Res"},{"key":"743_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-12-129","volume":"12","author":"E Langenfeld","year":"2013","unstructured":"Langenfeld E, Deen M, Zachariah E, Langenfeld J. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer. 2013;12:129.","journal-title":"Mol Cancer"},{"key":"743_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-016-0511-9","volume":"15","author":"DJ Augeri","year":"2016","unstructured":"Augeri DJ, Langenfeld E, Castle M, Gilleran JA, Langenfeld J. Inhibition of BMP and of TGFbeta receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer. 2016;15:27.","journal-title":"Mol Cancer"},{"key":"743_CR8","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1038\/s41388-018-0156-9","volume":"37","author":"JH Newman","year":"2018","unstructured":"Newman JH, Augeri DJ, NeMoyer R, Malhotra J, Langenfeld E, Chesson CB, Dobias NS, Lee MJ, Tarabichi S, Jhawar SR, et al. Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer. Oncogene. 2018;37:3672\u201385.","journal-title":"Oncogene"},{"key":"743_CR9","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/onc.2014.189","volume":"34","author":"P Owens","year":"2015","unstructured":"Owens P, Pickup MW, Novitskiy SV, Giltnane JM, Gorska AE, Hopkins CR, Hong CC, Moses HL. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2015;34:2437\u201349.","journal-title":"Oncogene"},{"key":"743_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1757-2215-2-4","volume":"2","author":"C Le Page","year":"2009","unstructured":"Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM. BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res. 2009;2:4.","journal-title":"J Ovarian Res"},{"key":"743_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cytogfr.2009.10.022","volume":"20","author":"J Nickel","year":"2009","unstructured":"Nickel J, Sebald W, Groppe JC, Mueller TD. Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev. 2009;20:367\u201377.","journal-title":"Cytokine Growth Factor Rev"},{"key":"743_CR12","doi-asserted-by":"publisher","first-page":"20948","DOI":"10.1074\/jbc.M800850200","volume":"283","author":"K Lavery","year":"2008","unstructured":"Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2\/4 and BMP-6\/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem. 2008;283:20948\u201358.","journal-title":"J Biol Chem"},{"key":"743_CR13","doi-asserted-by":"publisher","first-page":"19838","DOI":"10.1074\/jbc.274.28.19838","volume":"274","author":"A Hollnagel","year":"1999","unstructured":"Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem. 1999;274:19838\u201345.","journal-title":"J Biol Chem"},{"key":"743_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1046\/j.1365-2443.2002.00573.x","volume":"7","author":"T Katagiri","year":"2002","unstructured":"Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells. 2002;7:949\u201360.","journal-title":"Genes Cells"},{"key":"743_CR15","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1074\/jbc.M111023200","volume":"277","author":"O Korchynskyi","year":"2002","unstructured":"Korchynskyi O, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem. 2002;277:4883\u201391.","journal-title":"J Biol Chem"},{"key":"743_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12964-019-0469-5","volume":"17","author":"R NeMoyer","year":"2019","unstructured":"NeMoyer R, Mondal A, Vora M, Langenfeld E, Glover D, Scott M, Lairson L, Rongo C, Augeri DJ, Peng Y, et al. Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac\/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein. Cell Commun Signal. 2019;17:150.","journal-title":"Cell Commun Signal"},{"key":"743_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1083\/jcb.200212060","volume":"162","author":"VC Foletta","year":"2003","unstructured":"Foletta VC, Lim MA, Soosairajah J, Kelly AP, Stanley EG, Shannon M, He W, Das S, Massague J, Bernard O. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol. 2003;162:1089\u201398.","journal-title":"J Cell Biol"},{"key":"743_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1741-7007-12-43","volume":"12","author":"C Hiepen","year":"2014","unstructured":"Hiepen C, Benn A, Denkis A, Lukonin I, Weise C, Boergermann JH, Knaus P. BMP2-induced chemotaxis requires PI3K p55\u03b3\/p110\u03b1-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5\u03b2 recruitment at the cytocortex. BMC Biol. 2014;12:43.","journal-title":"BMC Biol"},{"key":"743_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.neuron.2012.12.015","volume":"77","author":"M Nahm","year":"2013","unstructured":"Nahm M, Lee MJ, Parkinson W, Lee M, Kim H, Kim YJ, Kim S, Cho YS, Min BM, Bae YC, et al. Spartin regulates synaptic growth and neuronal survival by inhibiting BMP-mediated microtubule stabilization. Neuron. 2013;77:680\u201395.","journal-title":"Neuron"},{"key":"743_CR20","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1093\/hmg\/ddp324","volume":"18","author":"HT Tsang","year":"2009","unstructured":"Tsang HT, Edwards TL, Wang X, Connell JW, Davies RJ, Durrington HJ, O\u2019Kane CJ, Luzio JP, Reid E. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet. 2009;18:3805\u201321.","journal-title":"Hum Mol Genet"},{"key":"743_CR21","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1523\/JNEUROSCI.2752-16.2017","volume":"37","author":"Y Akbergenova","year":"2017","unstructured":"Akbergenova Y, Littleton JT. Pathogenic huntington alters BMP signaling and synaptic growth through local disruptions of endosomal compartments. J Neurosci. 2017;37:3425\u201339.","journal-title":"J Neurosci"},{"key":"743_CR22","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1242\/jcs.031286","volume":"121","author":"C Gamell","year":"2008","unstructured":"Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci. 2008;121:3960\u201370.","journal-title":"J Cell Sci"},{"key":"743_CR23","doi-asserted-by":"publisher","first-page":"e8198","DOI":"10.1371\/journal.pone.0008198","volume":"4","author":"JC Perron","year":"2009","unstructured":"Perron JC, Dodd J. ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis. PLoS ONE. 2009;4:e8198.","journal-title":"PLoS ONE"},{"key":"743_CR24","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1128\/MCB.01166-09","volume":"30","author":"M Podkowa","year":"2010","unstructured":"Podkowa M, Zhao X, Chow CW, Coffey ET, Davis RJ, Attisano L. Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation. Mol Cell Biol. 2010;30:2241\u201350.","journal-title":"Mol Cell Biol"},{"key":"743_CR25","doi-asserted-by":"publisher","first-page":"34087","DOI":"10.1074\/jbc.C400236200","volume":"279","author":"T Dohi","year":"2004","unstructured":"Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, Marusawa H, Zou H, Armstrong R, Matsuzawa S, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem. 2004;279:34087\u201390.","journal-title":"J Biol Chem"},{"key":"743_CR26","doi-asserted-by":"publisher","first-page":"8014","DOI":"10.1158\/0008-5472.CAN-07-1343","volume":"67","author":"T Nakahara","year":"2007","unstructured":"Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, Takeuchi M, Tominaga F, Hatakeyama S, Kinoyama I, Matsuhisa A, et al. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res. 2007;67:8014\u201321.","journal-title":"Cancer Res"},{"key":"743_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00280-012-1868-0","volume":"70","author":"TG Glaros","year":"2012","unstructured":"Glaros TG, Stockwin LH, Mullendore ME, Smith B, Morrison BL, Newton DL. The \u201csurvivin suppressants\u201d NSC 80467 and YM155 induce a DNA damage response. Cancer Chemother Pharmacol. 2012;70:207\u201312.","journal-title":"Cancer Chemother Pharmacol"},{"key":"743_CR28","doi-asserted-by":"publisher","first-page":"22516","DOI":"10.1074\/jbc.M113.489328","volume":"288","author":"J Asthana","year":"2013","unstructured":"Asthana J, Kapoor S, Mohan R, Panda D. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. J Biol Chem. 2013;288:22516\u201326.","journal-title":"J Biol Chem"},{"key":"743_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0014-5793(98)01640-8","volume":"442","author":"P Schotte","year":"1999","unstructured":"Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 1999;442:117\u201321.","journal-title":"FEBS Lett"},{"key":"743_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.cdd.4401247","volume":"10","author":"J Rozman-Pungercar","year":"2003","unstructured":"Rozman-Pungercar J, Kopitar-Jerala N, Bogyo M, Turk D, Vasiljeva O, Stefe I, Vandenabeele P, Bromme D, Puizdar V, Fonovic M, et al. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 2003;10:881\u20138.","journal-title":"Cell Death Differ"},{"key":"743_CR31","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1242\/jcs.091181","volume":"126","author":"S Aits","year":"2013","unstructured":"Aits S, Jaattela M. Lysosomal cell death at a glance. J Cell Sci. 2013;126:1905\u201312.","journal-title":"J Cell Sci"},{"key":"743_CR32","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/onc.2008.310","volume":"27","author":"P Boya","year":"2008","unstructured":"Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27:6434\u201351.","journal-title":"Oncogene"},{"key":"743_CR33","doi-asserted-by":"publisher","first-page":"21783","DOI":"10.1074\/jbc.R109.023820","volume":"284","author":"B Turk","year":"2009","unstructured":"Turk B, Turk V. Lysosomes as \u201csuicide bags\u201d in cell death: myth or reality? J Biol Chem. 2009;284:21783\u20137.","journal-title":"J Biol Chem"},{"key":"743_CR34","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1073\/pnas.1319947111","volume":"111","author":"RJ Gleason","year":"2014","unstructured":"Gleason RJ, Akintobi AM, Grant BD, Padgett RW. BMP signaling requires retromer-dependent recycling of the type I receptor. Proc Natl Acad Sci USA. 2014;111:2578\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"743_CR35","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1128\/MCB.00022-06","volume":"26","author":"A Hartung","year":"2006","unstructured":"Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol. 2006;26:7791\u2013805.","journal-title":"Mol Cell Biol"},{"key":"743_CR36","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1083\/jcb.201705017","volume":"216","author":"SL Schmid","year":"2017","unstructured":"Schmid SL. Reciprocal regulation of signaling and endocytosis: Implications for the evolving cancer cell. J Cell Biol. 2017;216:2623\u201332.","journal-title":"J Cell Biol"},{"key":"743_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","volume":"21","author":"RE Lawrence","year":"2019","unstructured":"Lawrence RE, Zoncu R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol. 2019;21:133\u201342.","journal-title":"Nat Cell Biol"},{"key":"743_CR38","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1093\/hmg\/ddt216","volume":"22","author":"BJ Dunmore","year":"2013","unstructured":"Dunmore BJ, Drake KM, Upton PD, Toshner MR, Aldred MA, Morrell NW. The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations. Hum Mol Genet. 2013;22:3667\u201379.","journal-title":"Hum Mol Genet"},{"key":"743_CR39","doi-asserted-by":"publisher","first-page":"L474","DOI":"10.1152\/ajplung.00202.2011","volume":"302","author":"JA Johnson","year":"2012","unstructured":"Johnson JA, Hemnes AR, Perrien DS, Schuster M, Robinson LJ, Gladson S, Loibner H, Bai S, Blackwell TR, Tada Y, et al. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2012;302:L474-484.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"743_CR40","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1158\/0008-5472.CAN-06-3520","volume":"67","author":"L Groth-Pedersen","year":"2007","unstructured":"Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, Nylandsted J, Jaattela M. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res. 2007;67:2217\u201325.","journal-title":"Cancer Res"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-021-00743-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-021-00743-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-021-00743-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T04:50:58Z","timestamp":1673326258000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-021-00743-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["743"],"URL":"https:\/\/doi.org\/10.1186\/s12964-021-00743-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"11 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests of by any of the authors on the material in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}